Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients.

导出 OA

翻译打印收藏纠错

作者： Ahmed Kotb,Abdrabou ^[1] ; Fahad,Al Sharif ^[2] ; Riad,El Fakih ^[2] ; Hazaa Al,Zahrani ^[2] ; Ruah,Al Yamany ^[2] ; Mostafa,Saleh ^[2] ; Saud,Alhayli ^[2] ; Zakia,Al Somali ^[2] ; Ahmad,Alotaibi ^[2] ; AlFadel,AlShaibani ^[2] ; Farah,Deeba ^[2] ; Maryam,Asif ^[2] ; Syed Ahmed Osman Ali,Ahmed ^[2] ; Feras,Al Fraih ^[2] ; Marwan,Shaheen ^[2] ; Ali,Alahmari ^[2] ; Walid,Rasheed ^[2] ; Naeem Arshad,Chaudhri ^[2] ; Fahad,Al Mohareb ^[2] ; Mahmoud,Aljurf ^[2] ; Amr,Hanbali ^[2]

作者单位： From the Department of Hematology and Bone Marrow Transplant, Zagazig University, Zagazig, Egypt. ^[1] From the Adult Hematology, Stem Cell Transplant and Cellular Therapy, Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. ^[2]

主题词中年人(Middle Aged);人类(Humans);多发性骨髓瘤(Multiple Myeloma);生活质量(Quality of Life);回顾性研究(Retrospective Studies);存活率(Survival Rate);环磷酰胺(Cyclophosphamide)

DOI 10.5144/0256-4947.2024.93

PMID 38615184

发布时间 2024-04-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Annals of Saudi medicine

93-103页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients.

Annals of Saudi medicine

相似文献

Annals of Saudi medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients.

Annals of Saudi medicine

相似文献

Annals of Saudi medicine

相关期刊

检索历史清除